Your browser doesn't support javascript.
loading
MiR-30c suppresses the proliferation, metastasis and polarity reversal of tumor cell clusters by targeting MTDH in invasive micropapillary carcinoma of the breast.
Han, Yunwei; Li, Weidong; Zhi, Renyong; Ma, Gui; Gao, Ang; Wu, Kailiang; Sun, Hui; Zhao, Dan; Yang, Yiling; Liu, Fangfang; Gu, Feng; Guo, Xiaojing; Dong, Jintang; Li, Shuai; Fu, Li.
Afiliação
  • Han Y; Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
  • Li W; National Clinical Research Center of Cancer, Tianjin 300060, China.
  • Zhi R; Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.
  • Ma G; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Tianjin 300060, China.
  • Gao A; Ministry of Education, Breast Cancer Innovation Team of the Ministry of Education, Tianjin 300060, China.
  • Wu K; Key Laboratory of Cancer Prevention and Therapy, State Key Laboratory of Breast Cancer Research, Tianjin 300060, China.
  • Sun H; Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
  • Zhao D; National Clinical Research Center of Cancer, Tianjin 300060, China.
  • Yang Y; Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.
  • Liu F; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Tianjin 300060, China.
  • Gu F; Ministry of Education, Breast Cancer Innovation Team of the Ministry of Education, Tianjin 300060, China.
  • Guo X; Key Laboratory of Cancer Prevention and Therapy, State Key Laboratory of Breast Cancer Research, Tianjin 300060, China.
  • Dong J; Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
  • Li S; National Clinical Research Center of Cancer, Tianjin 300060, China.
  • Fu L; Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.
Heliyon ; 10(13): e33938, 2024 Jul 15.
Article em En | MEDLINE | ID: mdl-39071710
ABSTRACT

Purpose:

Invasive micropapillary carcinoma (IMPC) of the breast has a high propensity for lymphovascular invasion and axillary lymph node metastasis and displays an 'inside-out' growth pattern, but the molecular mechanism of invasion, metastasis and cell polarity reversal in IMPC is unclear.

Methods:

and Patients Cell growth curves, tumor sphere formation assays, transwell assays, mouse xenograft model and immunofluorescence were evaluated to investigate the effects of miR-30c and MTDH. Dual luciferase reporter assays was performed to confirm that the MTDH (metadherin) 3'UTR bound to miR-30c. MiRNA in situ hybridization (ISH) and immunohistochemistry (IHC) were carried out on IMPC patient tissues for miR-30c and MTDH expression, respectively.

Results:

We found miR-30c as a tumor suppressor gene in cell proliferation, metastasis and polarity reversal of IMPC. Overexpression of miR-30c inhibited cell growth and metastasis in vitro and in vivo. MiR-30c could directly target the MTDH 3'UTR. MiR-30c overexpression inhibited breast cancer cell proliferation, invasion and metastasis by targeting MTDH. Moreover, miR-30c/MTDH axis could also regulate cell polarity reversal of IMPC. By ISH and IHC analyses, miR-30c and MTDH were significantly correlated with tumor size, lymph nodule status and tumor grade, the 'inside-out' growth pattern, overall survival (OS) and disease-free survival (DFS) in IMPC patients.

Conclusions:

Overall, miR-30c/MTDH axis was responsible for tumor proliferation, metastasis and polarity reversal. It may provide promising therapeutic targets and prognostic biomarkers for patients with IMPC.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Heliyon Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Heliyon Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China